Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Strang

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitorsMelanie S Glossop, Richard J Bazin, Kevin N Dack, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2015
Molecular hybridization yields triazole bronchodilators for the treatment of COPDLyn H Jones, Jane Burrows, Neil Feeder, et al.
Journal of Medicinal Chemistry|August 30, 2011
Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary diseasePaul A Glossop, Christine A L Watson, David A Price, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitorsMelanie S Glossop, Richard J Bazin, Kevin N Dack, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2015
Molecular hybridization yields triazole bronchodilators for the treatment of COPDLyn H Jones, Jane Burrows, Neil Feeder, et al.
Journal of Medicinal Chemistry|August 30, 2011
Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary diseasePaul A Glossop, Christine A L Watson, David A Price, et al.
Pageof 3